MCM
DERM

Moore Capital Management’s Dermira, Inc. DERM Stock Holding History

Moore Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-75,000
Closed -$2.6M – 368
2015
Q4 		$2.6M Buy
+75,000
New +$2.15M 0.08% 185

Other funds holding DERM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Moore Capital Management's DERM Position: Q1 2016 in Review

Moore Capital Management sold out of Dermira, Inc. (DERM) in Q1 2016, closing a stake of 75,000 shares — an estimated $2.6M sold.

Moore Capital Management first reported a position in DERM in Q4 2015 and held it in 1 quarter. The position peaked at $2.6M in Q4 2015. 97 funds tracked by Wall St. Rank hold DERM as of Q1 2016.

  • Moore Capital Management reported no remaining Dermira, Inc. position as of Q1 2016 after selling out during the quarter.
  • Moore Capital Management sold 75,000 Dermira, Inc. shares in Q1 2016, an estimated $2.6M.
  • Moore Capital Management first reported a position in Dermira, Inc. in Q4 2015 and held it in 1 quarter.
  • Moore Capital Management's Dermira, Inc. position peaked at $2.6M in Q4 2015.
  • 97 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2016.

Based on Moore Capital Management's 13F filing for Q1 2016, filed 16 May 2016.